Streetbeat News

Products Services

JFBR

SPRC

Jeffs' Brands Ltd (NASDAQ:JFBR) announced that SciSparc Nutraceuticals, in which it owns a 49% equity interest, has entered into an exclusive license and distribution agreement to sell and market CannAmide on the Amazon.com marketplace in Canada. The license was granted by SciSparc Ltd. (NASDAQ:SPRC), a clinical-stage pharmaceutical company.

Portfolio Pulse from Vuk Zdinjak

June 07, 2023 | 1:42 pm

MSFT

OpenAI CEO stated that there is still a lot of work to be done before starting to train GPT-5, indicating that the development of the next-generation AI model may take longer than expected.

Portfolio Pulse from Happy Mohamed

June 07, 2023 | 1:42 pm

AFRM

AMZN

Affirm Holdings shares are trading higher after Amazon added Affirm's Adaptive Checkout as a payment option at checkout.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2023 | 1:38 pm

MU

Micron announces volume production availability of high-capacity 96GB DDR5 RDIMMs with speeds up to 4800MT/s, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2023 | 1:27 pm

LUV

T

Southwest Airlines has partnered with DIRECTV to provide live streaming channels on select flights. Aircraft equipped with Viasat inflight Wi-Fi will offer 14 DIRECTV channels, while DIRECTV and DIRECTV STREAM customers can access their full subscription for an additional $8.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2023 | 1:26 pm

MRVL

Marvell Technology's shares are trading higher after reports indicate the company has won Amazon's ASIC chip design contract.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2023 | 1:24 pm

BXRX

Baudax Bio announced top-line results from its Phase 2 randomized clinical trial of BX1000 for neuromuscular blockade in patients undergoing elective surgery. The trial met its primary and secondary endpoints.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2023 | 1:23 pm

VLVLY

Volvo has unveiled its cheapest electric vehicle, the EX30, according to a tweet by Electrek.

Portfolio Pulse from Happy Mohamed

June 07, 2023 | 1:22 pm

CAPR

Capricor Therapeutics (NASDAQ:CAPR) announced an upcoming Type-B clinical meeting with the FDA in early Q3 2023 to discuss the proposed path towards submission of a potential Biologics License Application (BLA) for CAP-1002, a treatment for Duchenne muscular dystrophy (DMD). The company expects to complete enrollment for its Phase 3 HOPE-3 clinical trial by the second half of 2023 and report interim analysis in Q4 2023.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2023 | 1:17 pm

BTCUSD

Benzinga interviewed Mike Germano, President of Bitcoin Magazine, at Bitcoin 2023 in Miami. Germano discussed the company's focus on promoting Bitcoin's potential for financial freedom and inclusion, as well as their plans to expand globally and bring their message to mainstream audiences.

Portfolio Pulse from Renato Capelj

June 07, 2023 | 1:12 pm